Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Mizoguchi

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|September 12, 2013
Roles of matrix metalloproteinases and their targets in epileptogenesis and seizuresHiroyuki Mizoguchi, Kiyofumi Yamada
Neurochemistry International|January 7, 2019
Methamphetamine use causes cognitive impairment and altered decision-makingHiroyuki Mizoguchi, Kiyofumi Yamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 17, 2019
[Physiological centers of decision-making: manipulation of neural activity in insular cortex by AAV]Hiroyuki Mizoguchi, Kiyofumi Yamada
Current Neuropharmacology|September 3, 2011
Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in MiceHiroyuki Mizoguchi, Kiyofumi Yamada
Plant Biotechnology (Tokyo, Japan)|January 12, 2026
Enhancement of bZIP60 function through C-terminal region translated after splicing in <i>Arabidopsis</i>Yuji Iwata, Hiroyuki Mizoguchi, Nozomu Koizumi
Journal of Pharmacological Sciences|January 17, 2008
Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodentsHiroyuki Mizoguchi, Kiyofumi Yamada, Toshitaka Nabeshima
Biochemistry Research International|January 12, 2012
Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsyHiroyuki Mizoguchi, Kiyofumi Yamada, Toshitaka Nabeshima
Biological & Pharmaceutical Bulletin|November 17, 2024
The Use of Text Mining to Obtain a Historical Overview of Research on Therapeutic Drug MonitoringTetsuo Matsuzaki, Hiroyuki Mizoguchi, Kiyofumi Yamada
International Journal of Molecular Sciences|June 2, 2021
Alzheimer's Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive ImpairmentTsuyoshi Nakai, Kiyofumi Yamada, Hiroyuki Mizoguchi
Journal of Pharmacological Sciences|March 18, 2022
A machine learning model that emulates experts' decision making in vancomycin initial dose planningTetsuo Matsuzaki, Yoshiaki Kato, Hiroyuki Mizoguchi, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|September 12, 2013
Roles of matrix metalloproteinases and their targets in epileptogenesis and seizuresHiroyuki Mizoguchi, Kiyofumi Yamada
Neurochemistry International|January 7, 2019
Methamphetamine use causes cognitive impairment and altered decision-makingHiroyuki Mizoguchi, Kiyofumi Yamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 17, 2019
[Physiological centers of decision-making: manipulation of neural activity in insular cortex by AAV]Hiroyuki Mizoguchi, Kiyofumi Yamada
Current Neuropharmacology|September 3, 2011
Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in MiceHiroyuki Mizoguchi, Kiyofumi Yamada
Plant Biotechnology (Tokyo, Japan)|January 12, 2026
Enhancement of bZIP60 function through C-terminal region translated after splicing in <i>Arabidopsis</i>Yuji Iwata, Hiroyuki Mizoguchi, Nozomu Koizumi
Journal of Pharmacological Sciences|January 17, 2008
Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodentsHiroyuki Mizoguchi, Kiyofumi Yamada, Toshitaka Nabeshima
Biochemistry Research International|January 12, 2012
Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsyHiroyuki Mizoguchi, Kiyofumi Yamada, Toshitaka Nabeshima
Biological & Pharmaceutical Bulletin|November 17, 2024
The Use of Text Mining to Obtain a Historical Overview of Research on Therapeutic Drug MonitoringTetsuo Matsuzaki, Hiroyuki Mizoguchi, Kiyofumi Yamada
International Journal of Molecular Sciences|June 2, 2021
Alzheimer's Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive ImpairmentTsuyoshi Nakai, Kiyofumi Yamada, Hiroyuki Mizoguchi
Journal of Pharmacological Sciences|March 18, 2022
A machine learning model that emulates experts' decision making in vancomycin initial dose planningTetsuo Matsuzaki, Yoshiaki Kato, Hiroyuki Mizoguchi, et al.
Pageof 10